Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis
Go back to Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis| TG THERAP (NASDAQ: TGTX) | Delayed: 59.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.06 | 52 Week High | $14.87 | |||
| Open | $59.06 | 52 Week Low | $4.90 | |||
| Day High | $59.06 | P/E | N/A | |||
| Day Low | $59.06 | EPS | $-0.67 | |||
| Volume | 12 | |||||
